DK0511800T3 - Farmaceutisk formulering indeholdende dirithromycin - Google Patents

Farmaceutisk formulering indeholdende dirithromycin

Info

Publication number
DK0511800T3
DK0511800T3 DK92303753.5T DK92303753T DK0511800T3 DK 0511800 T3 DK0511800 T3 DK 0511800T3 DK 92303753 T DK92303753 T DK 92303753T DK 0511800 T3 DK0511800 T3 DK 0511800T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical formulation
formulation containing
dirithromycin
containing dirithromycin
tablet containing
Prior art date
Application number
DK92303753.5T
Other languages
Danish (da)
English (en)
Inventor
James Michael Greene
Holly Marie Hankins
Gregory Alan Stephenson
David Dale Wirth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0511800T3 publication Critical patent/DK0511800T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Formation And Processing Of Food Products (AREA)
DK92303753.5T 1991-04-29 1992-04-27 Farmaceutisk formulering indeholdende dirithromycin DK0511800T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US69284291A 1991-04-29 1991-04-29

Publications (1)

Publication Number Publication Date
DK0511800T3 true DK0511800T3 (da) 1997-04-21

Family

ID=24782254

Family Applications (2)

Application Number Title Priority Date Filing Date
DK92303753.5T DK0511800T3 (da) 1991-04-29 1992-04-27 Farmaceutisk formulering indeholdende dirithromycin
DK92303752.7T DK0511799T3 (da) 1991-04-29 1992-04-27 Farmaceutiske forbindelser

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92303752.7T DK0511799T3 (da) 1991-04-29 1992-04-27 Farmaceutiske forbindelser

Country Status (27)

Country Link
EP (2) EP0511799B1 (no)
JP (2) JP3135672B2 (no)
KR (2) KR100193742B1 (no)
CN (2) CN1030611C (no)
AT (2) ATE138924T1 (no)
AU (2) AU646734B2 (no)
BR (2) BR9201540A (no)
CA (2) CA2067275C (no)
CY (2) CY1946A (no)
CZ (2) CZ282021B6 (no)
DE (2) DE69214710T2 (no)
DK (2) DK0511800T3 (no)
ES (2) ES2093779T3 (no)
FI (2) FI101795B (no)
GR (2) GR3020439T3 (no)
HK (2) HK153696A (no)
HU (2) HU213613B (no)
IE (2) IE76296B1 (no)
IL (2) IL101705A (no)
MX (2) MX9201944A (no)
MY (2) MY109498A (no)
NO (2) NO179504C (no)
NZ (2) NZ242506A (no)
RU (2) RU2070203C1 (no)
TW (2) TW315371B (no)
YU (2) YU44392A (no)
ZA (2) ZA922777B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW271400B (no) * 1992-07-30 1996-03-01 Pfizer
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
DE29724846U1 (de) * 1996-07-29 2004-12-16 Abbott Laboratories, Abbott Park Herstellung von kristalliner Form II von Clarithromycin
TR199900651T2 (xx) * 1996-09-24 1999-07-21 Eli Lilly And Company Kaplanm�� par�ac�k form�lasyonu.
US6390690B1 (en) 2000-05-17 2002-05-21 3M Innovative Properties Company Fiber optic connector for coupling devices on intersecting planes
CN101547931B (zh) * 2006-12-05 2012-11-14 辉瑞有限公司 促动内酯多晶型
CN102145008B (zh) * 2010-12-29 2013-06-05 辰欣药业股份有限公司 一种地红霉素药物组合物及其制备方法
CN107151261B (zh) * 2017-06-09 2020-06-12 广州大光制药有限公司 一种地红霉素化合物的晶型及其结晶制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2515075C2 (de) * 1975-04-07 1985-10-24 Dr. Karl Thomae Gmbh, 7950 Biberach Erythromycinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
EP0184921A3 (en) * 1984-12-08 1986-10-29 Beecham Group Plc Erythromycin derivatives
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
EP0511800B1 (en) 1996-10-23
DK0511799T3 (da) 1996-06-24
DE69211220T2 (de) 1996-11-07
KR100194307B1 (ko) 1999-06-15
HU9203168D0 (en) 1992-12-28
FI101795B1 (fi) 1998-08-31
AU646734B2 (en) 1994-03-03
MY109498A (en) 1997-02-28
IE74885B1 (en) 1997-08-13
EP0511800A1 (en) 1992-11-04
HUT63956A (en) 1993-11-29
NO180450B (no) 1997-01-13
ZA922776B (en) 1993-10-15
MY114226A (en) 2002-09-30
NO179504C (no) 1996-10-23
ATE144425T1 (de) 1996-11-15
NO179504B (no) 1996-07-15
RU2045953C1 (ru) 1995-10-20
HUT62595A (en) 1993-05-28
CA2067275A1 (en) 1992-10-30
KR100193742B1 (ko) 1999-06-15
NZ242506A (en) 1993-09-27
CY1975A (en) 1997-09-05
FI921876A (fi) 1992-10-30
NO180450C (no) 1997-04-23
DE69214710T2 (de) 1997-03-13
JP3333545B2 (ja) 2002-10-15
CN1030611C (zh) 1996-01-03
NZ242505A (en) 1993-06-25
CS127792A3 (en) 1992-11-18
HK215096A (en) 1996-12-13
YU44392A (sh) 1994-12-28
ES2093779T3 (es) 1997-01-01
AU1525592A (en) 1992-11-05
EP0511799A1 (en) 1992-11-04
CA2067274C (en) 2002-10-15
DE69214710D1 (de) 1996-11-28
GR3020439T3 (en) 1996-10-31
DE69211220D1 (de) 1996-07-11
IE921346A1 (en) 1992-11-04
CN1066270A (zh) 1992-11-18
CZ282021B6 (cs) 1997-04-16
TW216399B (no) 1993-11-21
IL101705A (en) 1996-01-31
MX9201944A (es) 1992-11-01
IE921345A1 (en) 1992-11-04
HU9201398D0 (en) 1992-07-28
MX9201946A (es) 1992-11-01
CZ282218B6 (cs) 1997-06-11
HU213613B (en) 1997-08-28
KR920019364A (ko) 1992-11-19
CA2067274A1 (en) 1992-10-30
ATE138924T1 (de) 1996-06-15
BR9201540A (pt) 1992-12-01
CA2067275C (en) 2002-11-26
NO921617L (no) 1992-10-30
CN1069197C (zh) 2001-08-08
FI921877A (fi) 1992-10-30
IL101704A0 (en) 1992-12-30
TW315371B (no) 1997-09-11
HU215917B (hu) 1999-03-29
IL101704A (en) 1998-02-22
CS127692A3 (en) 1992-11-18
JPH05117289A (ja) 1993-05-14
NO921616L (no) 1992-10-30
BR9201541A (pt) 1992-12-01
KR920019365A (ko) 1992-11-19
JP3135672B2 (ja) 2001-02-19
NO921617D0 (no) 1992-04-27
EP0511799B1 (en) 1996-06-05
ZA922777B (en) 1993-10-15
FI921876A0 (fi) 1992-04-27
CN1066186A (zh) 1992-11-18
IL101705A0 (en) 1992-12-30
CY1946A (en) 1992-04-27
HK153696A (en) 1996-08-16
YU44492A (sh) 1994-06-24
FI921877A0 (fi) 1992-04-27
AU655978B2 (en) 1995-01-19
IE76296B1 (en) 1997-10-08
JPH05117154A (ja) 1993-05-14
GR3021706T3 (en) 1997-02-28
NO921616D0 (no) 1992-04-27
ES2088098T3 (es) 1996-08-01
AU1525792A (en) 1992-11-05
RU2070203C1 (ru) 1996-12-10
FI101795B (fi) 1998-08-31

Similar Documents

Publication Publication Date Title
FI934914A (fi) Farmaceutiska formuleringar
FI921060A0 (fi) Farmaceutiska aerosolformuleringar.
FI922958A0 (fi) Farmaceutisk sammansaettning.
FI922252A0 (fi) Farmaceutisk sammansaettning.
FI922316A0 (fi) Farmaceutisk sammansaettning.
FI923581A0 (fi) Farmaceutisk kombinationsformation.
DK0511800T3 (da) Farmaceutisk formulering indeholdende dirithromycin
FI923371A (fi) En farmaceutisk formulation.
MX9201791A (es) Medicamentos.